CXCR6 up-regulation immediately precedes or accompanies loss of TCF-1 expression in tumor-reactive PD-1+ CD8+T cells, whose specificity is infered by the expression of PD1, a marker enriched within anti-tumor T cells (Figure 1). Here, CD8A is linked to neoplasm.